CB1 antagonist 2
CB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3, inhibits CB1 in vivo with an IC50 of 25.5 nM[1].
Product Specifications
CAS Number
614726-85-1
Product Name Alternative
AM4113
UNSPSC
12352005
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/cb1-antagonist-2.html
Purity
99.91
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=C(N)C1=NN(C(C2=CC=C(C=C2)Cl)=C1C)C3=CC=C(C=C3Cl)Cl
Molecular Formula
C17H12Cl3N3O
Molecular Weight
380.66
References & Citations
[1]Song Li, et al. 4-methyl-diaryl -1H- pyrazole derivatives and their use as medicamentsFIELD.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC401070-500 1x 500 µL
TRAcP (Tartarate Resistant Acid Phosphatase) (ACP5/1070), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
PKSV030389-01 50 µg
Recombinant SARS-CoV-2 S-trimer (D614G, N439K) (His Tag)
Sign In for Pricing
View Details PKSV030389-02 500 µg
Recombinant SARS-CoV-2 S-trimer (D614G, N439K) (His Tag)
Sign In for Pricing
View Details 
